Dr. Berenson is the founder and president for the Berenson Cancer Center, a prolific specialty practice in West Hollywood, CA focused on the treatment of patients with multiple myeloma and related malignancies and conditions. More than 600 patients under his care. Dr Berenson is also the CEO of ONCOtherapeutics, a specialized CRO leading preclinical research and clinical trials from phase I to IV in community oncology sites throughout the United States.
In 2003, he founded the Institute for Myeloma & Bone Cancer Research (IMBCR), a mission-driven 501(C)3 non-profit institute dedicated to advance the treatment of myeloma by connecting possibility through scientific innovation leading to personalized and continuous optimized patient care.
Dr. Berenson has authored more than 300 peer-reviewed publications and written books (and many book chapters) related to multiple myeloma. He serves as a member of the National Institutes of Health – Center for Scientific Review, Clinical Oncology Study Section, and is a member of the Scientific Boards of the Multiple Myeloma Research Foundation and the International Myeloma Foundation. Dr. Berenson has served on both the Foundation and the Scientific Boards of the Multiple Myeloma Research Foundation, International Myeloma Foundation, and International Waldenstrom’s Macroglobulinemia Foundation.